A significant advance in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial malignant protector protein is frequently lost in several forms of tumors, leading https://freebookmarkpost.com/story21789402/vhh-fragments-reactivate-tumor-suppressor-p53-a-promising-approach-for-tumor-therapy